Journal of Vaccines & Vaccination

10^th Euro Global Summit and Expo on Vaccines & Vaccination

June 16-18, 2016 Rome, Italy

Scientific Tracks Abstracts

• Pre-clinical evaluation of the therapeutic application of a vaccine targeting the 12 protease cleavage sites

  Ma Luo, D Tang, J Pinto, M Nykoluk, P Lacap, J Tuff, E Shadabi, C Czarnecki, J Whitney, M Alonso, T Ball, G Kobinger, P Sandstrom and F Plummer

  PDF HTML

• Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by live attenuated SIV

  Qingsheng Li

  PDF HTML

• Tat, the forgotten target that could help to cure from HIV

  Erwann P Loret

  PDF HTML

• Community engagement during the Ebola vaccine trial in Guinea

  Godwin Enwere

  PDF HTML

• Pre-clinical toxicology considerations in vaccine

  Nabil Al-Humadi

  PDF HTML

• Codon harmonization, a step beyond optimization to capture the natural rhythm of protein translation

  Bettina Werle, N Mariano, C Mignon, S Chenavas, G Stadthagen, A Lugari, C Perot, S Donnat, P Lagoutte F Diot and R Sodoyer

  PDF HTML

• Development of lipid based oral vaccine formulations

  Sarah Margaret Hook

  PDF HTML

• Viral vectored genetic vaccines: Current status and future perspectives

  Antonella Folgori

  PDF HTML

• Active immunization against proprotein convertase subtilisin/kexin type 9 (PCSK9): A new strategy to control hyperlipidemia

  Gunther Staffler

  PDF HTML

• Development of a production and purification platform for virus like particles (VLP) vaccine candidates: A case study

  Anissa Boumlic-Courtade

  PDF HTML

• Implementing a randomized control trial (RCT) in the context of an Ebola epidemic

  Ana Maria Henao Restrepo

  PDF HTML

• Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge

  Peter Burkhard, Christopher Karch, Jianping Li, Caroline Kulangara, Sara M Paulillo, Senthil K Raman, Sharareh Emadi, Anmin Tan, Zeinab H Helal, Qing Fan, and Mazhar I Khan

  PDF HTML

• Plant expression platforms for vaccine production

  Kathleen Hefferon

  PDF HTML

• What do Lebanese women know about cervical cancer and human papillomavirus prevention? A report on awareness levels in urban communities

  Jacques Choucair and Sara Abboud

  PDF HTML

• Isolation and characteristics identification of bovine rotaviruses from vaccinated dairy calves in Morocco

  Ennima Imane, Sebbar Ghizlane, Harif Bachir, Amzazi Saaid, Loutfi Chafiqa and Touil Nadia

  PDF HTML

• Bluetongue virus (BTV) serological survey and evidence of emergent BTV-8 serotype in Morocco

  Kamar Drif

  PDF HTML

• Evaluation of the protection conferred by an attenuated vaccine (Mass-type H120) of avian infectious bronchitis against a new emerging Italy 02 genotype in Moroccan broiler chickens

  Khadija Khataby, Faouzi Kichou, Chafiqa Loutfi and My Mustapha Ennaji

  PDF HTML

• Rapid development of an oral Zika virus vaccine

  Sean N Tucker, Emery Dora and Christina Joyce

  PDF HTML

• Preclinical development of HeV-sG as a vaccine and m102.4 as a post exposure prophylaxis against henipavirus infections

  Timothy R Fouts

  PDF HTML

• Measles: Need for continued vaccination and novel vaccines post virus eradication

  S Louise Cosby

  PDF HTML

• Evaluation of genetic stability of transgenes in vaccine

  Ali Azizi

  PDF HTML

• Process development for pneumococcal protein vaccines based on recombinant pneumococcal surface protein A (PspA) and hybrids of PspA and pneumolysin toxoid

  Viviane Maimoni Goncalves, Stefanie Kraschowetz, Douglas Borges de Figueiredo, Eneas Carvalho, Gilson Campani Jr, Gabriel Gonçalves, Eliane N Miyaji, Thiago R Converso, Luciana C C Leite, Teresa C Zangirolami and Joaquin Cabrera-Crespo

  PDF HTML

• The key person influences flu vaccination among health workers: Perspective study of social network

  Xiaoning Hao, Tao Bo and Jianchun Liu

  PDF HTML

• Pneumococcal conjugate vaccine: Use of pneumococcal surface protein A (PspA) as carrier

  Giovana Cappio Barazzone

  PDF HTML

• Pneumococcal inactivated whole cell vaccine: Development of the production process

  Viviane Maimoni Goncalves

  PDF HTML

• Knowledge, attitude and practices and influencing factors related to seasonal influenza vaccination among healthcare workers in Qingdao, China, 2013-14: A prospective cohort study

  Xiaoning Hao, Tao Bo and Zhi Liu

  PDF HTML

• Polio outbreak review in the Middle East and polio immunization mop-up campaigns in the Lebanese/ Syrian refugees context and post campaign results

  Randa Hamadeh, Walid Ammar and Gabriele Riedner

  PDF HTML

• Prevalence of tuberculin negativity after BCG vaccination in the under five Saudi children and the need for revaccination

  Fahad Saleh Al-Tayyeb

  PDF HTML

• Vaccination of hepatitis B in healthy adults: Effect of sex and age, two protocols of revaccination in nonresponders

  Jacques Choucair and Zaki Sleiman

  PDF HTML

• Expanding the findings of RV144 to South Africa: P5 initiative

  Glenda Gray

  PDF HTML

• Therapeutic vaccination with Tat restores immune homeostasis, promotes proviral DNA decay and induces cross clade neutralizing antibodies in patients on HAART: Results from phase II clinical trials in Italy and South Afr

  Barbara Ensoli

  PDF HTML

• Current strategies for HIV remission: The role of therapeutic vaccines

  Felipe Garcia Alcaide

  PDF HTML

• Synthetic DNA vaccines for difficult mucosal viruses including HIV

  Jean D Boyer

  PDF HTML

• Potential development of inactivated HIV-1 transmitted/founder virus (T/F) vaccine

  Adan Rios, Ethan C Pottet, Edward B Siwak, Dallas W Anderson and Qizhi C Yao

  PDF HTML

• HIV vaccine development: Is a moral wrong occurring?

  Mike King

  PDF HTML

• Reverse HIV vaccinology failed because it has no sound theoretical basis in the case of this virus

  Van Regenmortel Marc Hubert Victor

  PDF HTML

• HIV replication is suppressed by CD8+T regulatory cells in elite controllers

  Jean-Marie Andrieu

  PDF HTML

• Concerns in the planning of therapeutic immunizations in HIV infected patients aiming to harness HLA E restricted CD8+T cell HIV suppressive activity

  Eric Sandstrom

  PDF HTML

• Multiple immunogenetic aspects in susceptibility to HIV-1 infection progression toward AIDS and rational vaccine design

  Massimo Amicosante

  PDF HTML

• Multiple immunogenetic aspects in susceptibility to HIV-1 infection progression toward AIDS and rational vaccine design

  Massimo Amicosante

  PDF HTML

• Vaccines for pregnant women - challenges and opportunities for harmonized safety monitoring

  Sonali Kochhar

  PDF HTML

• Exploiting a high dose murine challenge model for HSV to identify potential DNA prime subunit boost vaccine strategies that could be translated to human clinical trials

  Timothy R Fouts

  PDF HTML

• Operational experience and lessons learned on influenza vaccination post authorization safety studies

  Ombretta Palucci

  PDF HTML

• Operational experience and lessons learned on influenza vaccination post authorization safety studies

  Ombretta Palucci

  PDF HTML

• Post-marketing surveillance of BCG vaccination

  Ruwen Jou

  PDF HTML

• Novel vaccine adjuvants for animal infectious diseases

  Jishu Shi

  PDF HTML

• Emerging market challenges: Development of a thermostable and immunologically active solid HPV vaccine formulation

  Ramesh Chintala

  PDF HTML

• Immunogenicity of VLP forming baculoviral DNA vaccine

  Young Bong Kim, Yong-Dae Gwon, Sehyun Kim, Yeondong Cho, Yoonki Heo, Hansam Cho, Kihoon Park, Hee-Jung Lee and Jiwon Choi

  PDF HTML

• Targeting TLR9 and TLR21 to develop vaccine adjuvant for different species

  Tsung-Hsien Chuang

  PDF HTML

• Therapeutic vaccines for treatment of allergic and autoimmune diseases

  Zhikang Peng

  PDF HTML

• Therapeutic vaccines against chronic hepatitis-B virus and related complications

  Sheikh Mohammad Fazle Akbar

  PDF HTML